NIH Guide: Weekly Index for December 22, 2023

Funding Opportunities

• Geroscience Course (R25 Independent Clinical Trial Not Allowed)
  (PAR-23-315)
  National Institute on Aging
  Office of Dietary Supplements
  Application Receipt Date(s): February 14, 2024
• NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
  (PAR-24-074)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): January 30, 2026
• Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
  (PAR-24-075)
  Office of the Director, NIH
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): December 28, 2026
• Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
  (PAR-24-076)
  Office of the Director, NIH
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  Application Receipt Date(s): December 28, 2026
• Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
  (PAR-24-080)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 9, 2025
• NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
  (PAR-24-083)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 20, 2024
• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  (PAR-24-084)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 20, 2024
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  (PAR-24-086)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 17, 2026
• Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
  (PAR-24-087)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): July 16, 2024
• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
  (PAR-24-090)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)
  (RFA-AA-24-001)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): April 9, 2024
• High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed)
  (RFA-AA-24-002)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): April 9, 2024
• Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-AI-24-002)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 21, 2024
• Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
  (RFA-DA-25-007)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)
  (RFA-DA-25-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 13, 2024
• Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders (UG3/UH3 Clinical Trial Optional)
  (RFA-DA-25-028)
  National Institute on Drug Abuse
  Application Receipt Date(s): July 9, 2024
• NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (RFA-DC-24-007)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): February 6, 2025
• National Project to Support and Promote Consistent Implementation of the Regulatory Standards for the Growing, Harvesting, Packing and Holding of Produce for Human Consumption and Produce Regulatory Standards (PRPS) (U2F) -Cooperative Agreements
  (RFA-FD-24-012)
  Food and Drug Administration
  Application Receipt Date(s): June 10, 2024
• Public Health Regulatory Systems Strengthening - U01 Clinical Trials Not Allowed
  (RFA-FD-24-015)
  Food and Drug Administration
  Application Receipt Date(s): February 29, 2024
• Produce Safety Alliance-U01 Clinical Trials Not Allowed
  (RFA-FD-24-018)
  Food and Drug Administration
  Application Receipt Date(s): February 29, 2024
• Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Clinical Trials Not Allowed
  (RFA-FD-24-020)
  Food and Drug Administration
  Application Receipt Date(s): January 27, 2024
• Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
  (RFA-FD-24-025)
  Food and Drug Administration
  Application Receipt Date(s): March 18, 2024
• Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed
  (RFA-FD-24-026)
  Food and Drug Administration
  Application Receipt Date(s): February 27, 2024
• Critical Path Public Private Partnerships Clinical Trials Optional
  (RFA-FD-24-027)
  Food and Drug Administration
  Application Receipt Date(s): March 4, 2024
• Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Optional)
  (RFA-NR-24-003)
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): March 22, 2024